Literature DB >> 29651973

The Clinical and Immunological Features of Patients with Primary Antibody Deficiencies.

Gholamreza Azizi1,2,3, Yasser Bagheri4,5, Marzieh Tavakol6, Forough Askarimoghaddam6, Kumars Porrostami7, Hosein Rafiemanesh8,9, Reza Yazdani2, Fatemeh Kiaee2,3, Sima Habibi2,3, Kosar Abouhamzeh2, Hamed Mohammadi10,11, Mostafa Qorbani12, Hassan Abolhassani2,3,13, Asghar Aghamohammadi2,3.   

Abstract

BACKGROUND: Primary antibody deficiency (PAD) comprises a range of diseases from early to late terminal B cells defects and is associated with the various clinical complications.
METHODS: A total of 461 patients (311 males and 150 females) with PADs enrolled in the retrospective cohort study and for all patients' demographic information, clinical records and laboratory data were collected to investigate clinical complications.
RESULTS: The most prevalent first presentations of immunodeficiency were respiratory tract infections in 63.5% and chronic diarrhea in 17.2%. Common variable immune deficiency (CVID) patients had a higher diagnostic delay than class switching defect (CSD), and agammaglobulinemia. Among the noninfectious complications, autoimmunity (26.2%), and splenomegaly (23.4%) were the most common. Lymphadenopathy was higher in CSD patients than other PADs, while splenomegaly, hepatomegaly, autoimmunity and bronchiectasis were more common in CVID patients than others. Atopic manifestations were mostly recorded in patients with selective IgA deficiency. Malignancy was only reported in 5.8% of patients with CVID. There was a higher prevalence of autoimmune manifestations in CVID comparing to other PADs.
CONCLUSION: PADs are relatively rare diseases and these patients have a variety of first clinical manifestations, such as diverse infections, autoimmunity, lymphoproliferation, allergy, enteropathy and malignancy. Practitioner's awareness about the heterogeneous presentations of PAD disorders is poor, therefore patients often are lately diagnosed, and they are complicated with several clinical complications before the certain diagnosis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  CVID; Primary antibody deficiencies; infection; morbidity and mortality; non-infectious complication; respiratoryzzm321990tract infection.

Mesh:

Substances:

Year:  2018        PMID: 29651973     DOI: 10.2174/1871530318666180413110216

Source DB:  PubMed          Journal:  Endocr Metab Immune Disord Drug Targets        ISSN: 1871-5303            Impact factor:   2.895


  3 in total

1.  Primary antibody deficiencies in Turkey: molecular and clinical aspects.

Authors:  Sinem Firtina; Yuk Yin Ng; Ozden H Ng; Ayca Kiykim; Esra Yucel Ozek; Manolya Kara; Elif Aydiner; Serdar Nepesov; Yildiz Camcioglu; Esra H Sayar; Ezgi Yalcin Gungoren; Ismail Reisli; Selda H Torun; Sule Haskologlu; Tuba Cogurlu; Aysenur Kaya; Sukru Cekic; Safa Baris; Ugur Ozbek; Ahmet Ozen; Muge Sayitoglu
Journal:  Immunol Res       Date:  2021-10-07       Impact factor: 2.829

2.  Familial inheritance and screening of first-degree relatives in common variable immunodeficiency and immunoglobulin A deficiency patients.

Authors:  Neslihan Edeer Karaca; Ezgi Ulusoy Severcan; Burcu Guven Bilgin; Elif Azarsiz; Sanem Akarcan; Nursen Cigerci Gunaydın; Nesrin Gulez; Ferah Genel; Guzide Aksu; Necil Kutukculer
Journal:  Int J Immunopathol Pharmacol       Date:  2018 Jan-Dec       Impact factor: 3.219

3.  Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy.

Authors:  Ahmed Dawood Mohammed; Md A Wadud Khan; Ioulia Chatzistamou; Douja Chamseddine; Katie Williams-Kang; Mason Perry; Reilly Enos; Angela Murphy; Gregorio Gomez; Ahmed Aladhami; Carole A Oskeritzian; Amy Jolly; Yan Chang; Shuqian He; Zui Pan; Jason L Kubinak
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.